病态肥胖关节痛患者的结局:一项回顾性研究
本研究回顾性分析病态肥胖(BMI 40-49.9 kg/m2)和超级肥胖(BMI≥50 kg/m2)的髋或膝骨关节炎患者,评估骨科医生建议减重的效果。结果显示BMI每增加1 kg/m2,接受全关节置换术(TJA)的几率降低10.9%;仅少数非手术患者(23.0%)和术前TJA患者(17.9%)实现临床有意义减重(>5%),术后增至30.2%。结论认为减重是不稳定可改变的风险因素。
要点
- BMI每增加1 kg/m2,TJA几率降低10.9%(OR=0.891)。
- 超级肥胖患者更常被转诊至体重管理(52.0% vs 21.7%)。
- 仅23.0%非手术患者和17.9%术前TJA患者实现>5%减重。
核心结论
- 在病态和超级肥胖患者中,BMI增加降低接受TJA的可能性。
- 经骨科医生建议后,少数患者参与减重项目或能够减重。
- 减重是关节置换手术不一致可改变的风险因素。
研究设计与样本
- 回顾性研究,纳入病态肥胖(BMI 40-49.9 kg/m2)和超级肥胖(BMI≥50 kg/m2)的髋或膝骨关节炎患者。
- 排除随访不足3个月的患者,记录患者特征、疾病特征和治疗。
主要发现
- 超级肥胖患者更可能被转诊至体重管理(52.0% vs 21.7%,P < .001)。
- 超级肥胖患者接受TJA的比例更低(20.0% vs 41.7%,P = .004)。
- BMI每增加1 kg/m2,TJA几率降低10.9%(OR=0.891,95%CI:0.833-0.953,P = .001)。
- 非手术治疗患者中40例(23.0%)实现临床有意义减重(>5%),TJA患者术前19例(17.9%)减重,术后增至32例(30.2%)。
关键数值与推荐
- 临床有意义减重定义为体重减轻大于5%。
- 病态肥胖定义为BMI 40-49.9 kg/m2,超级肥胖定义为BMI≥50 kg/m2。
临床怎么用
- 骨科医生应认识到建议减重可能效果有限,需结合其他管理策略。
- 对病态肥胖和超级肥胖患者,应评估减重干预的可行性和支持措施。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The number of obese patients seeking a total joint arthroplasty (TJA) continues to increase. Weight loss is often recommended to treat joint pain and reduce risks associated with TJA. We sought to determine the effectiveness of an orthopedic surgeon's recommendation to lose weight. METHODS: We identified morbidly obese (body mass index (BMI) 40-49.9 kg/m2) and super obese (BMI ≥50 kg/m2) patients with hip or knee osteoarthritis. Patients with less than 3-month follow-up were excluded. Patient characteristics (age, gender, BMI, comorbidities), disease characteristics (joint affected, radiographic osteoarthritis grading), and treatments were recorded. Clinically meaningful weight loss was defined as weight loss greater than 5%. RESULTS: Two hundred thirty morbid and 50 super obese patients were identified. Super obese patients were more likely to be referred to weight management (52.0% vs 21.7%, P < .001) and were less likely to receive TJA (20.0% vs 41.7%, P = .004). Each 1 kg/m2 increase in BMI decreased the odds of TJA by 10.9% (odds ratio = 0.891, 95% confidence interval: 0.833-0.953, P = .001). Forty (23.0%) of the nonoperatively treated patients achieved clinically meaningful weight loss, and 19 (17.9%) patients who underwent TJA lost weight before surgery. After surgery, the number of patients who achieved a clinically meaningful weight loss grew to 32 (30.2%). CONCLUSION: In morbid and super obese patients, increasing BMI reduces the likelihood that a patient will receive TJA, and when counseled by their orthopedic surgeon, few patients participate in weight-loss programs or are otherwise able to lose weight. Weight loss is an inconsistently modifiable risk factor for joint replacement surgery.
引用
- Reeves RA, Hefter GD, Pellegrini VD, et al. The Fate of Morbidly Obese Patients With Joint Pain: A Retrospective Study of Patient Outcomes. J Arthroplasty. 2021. PMID: 33757715. doi:10.1016/j.arth.2021.02.069
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。